container_end_page
container_issue 9
container_start_page ECR32
container_title Haematologica (Roma)
container_volume 89
creator Tamura, Takahiro
Tasaka, Taizo
Fujimoto, Miharu
Matsuhashi, Yoshiko
Fukumot, Tetsuya
Mano, Shohei
Kuwajima, Minoru
Nagai, Masami
description
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_15377484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15377484</sourcerecordid><originalsourceid>FETCH-LOGICAL-p124t-be414fbef70fc153ccddc25a029b516c9e077b4b636f9c0cd086a499d9277f33</originalsourceid><addsrcrecordid>eNo1j81KxDAUhYMgzjj6CnJfoJCmadMsZfAPZnAz-yFJb2y0TUqSsfTtLairczbn4ztXZFvWkhWtYOWG3Kb0SSmjUoobsinrSgje8i3xR5WS-0bQwSOMKsYwg0cTQ3IJnAcFk8oOfYbZ5R5MH4N3BsYFh2CWvNYBL184OgU2DEOYnf8AN64b7zSMmJZBZYTcY1TTckeurRoS3v_ljpyen0771-Lw_vK2fzwUU8l4LjTykluNVlBrVlljus6wWlEmdV02RiIVQnPdVI2VhpqOto3iUnaSCWGrakcefrHTRY_Ynae4GsXl_P-7-gFTUVaw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><creator>Tamura, Takahiro ; Tasaka, Taizo ; Fujimoto, Miharu ; Matsuhashi, Yoshiko ; Fukumot, Tetsuya ; Mano, Shohei ; Kuwajima, Minoru ; Nagai, Masami</creator><creatorcontrib>Tamura, Takahiro ; Tasaka, Taizo ; Fujimoto, Miharu ; Matsuhashi, Yoshiko ; Fukumot, Tetsuya ; Mano, Shohei ; Kuwajima, Minoru ; Nagai, Masami</creatorcontrib><identifier>EISSN: 1592-8721</identifier><identifier>PMID: 15377484</identifier><language>eng</language><publisher>Italy</publisher><subject>Acute Kidney Injury - complications ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Benzamides ; Bone Marrow - drug effects ; Bone Marrow - pathology ; Disseminated Intravascular Coagulation - complications ; Fatal Outcome ; Female ; Fusion Proteins, bcr-abl - antagonists &amp; inhibitors ; Humans ; Imatinib Mesylate ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Middle Aged ; Necrosis ; Neoplasm Proteins - antagonists &amp; inhibitors ; Piperazines - adverse effects ; Piperazines - therapeutic use ; Pneumonia - complications ; Protein Kinase Inhibitors - adverse effects ; Protein Kinase Inhibitors - therapeutic use ; Pyrimidines - adverse effects ; Pyrimidines - therapeutic use</subject><ispartof>Haematologica (Roma), 2004-09, Vol.89 (9), p.ECR32</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15377484$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tamura, Takahiro</creatorcontrib><creatorcontrib>Tasaka, Taizo</creatorcontrib><creatorcontrib>Fujimoto, Miharu</creatorcontrib><creatorcontrib>Matsuhashi, Yoshiko</creatorcontrib><creatorcontrib>Fukumot, Tetsuya</creatorcontrib><creatorcontrib>Mano, Shohei</creatorcontrib><creatorcontrib>Kuwajima, Minoru</creatorcontrib><creatorcontrib>Nagai, Masami</creatorcontrib><title>Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy</title><title>Haematologica (Roma)</title><addtitle>Haematologica</addtitle><subject>Acute Kidney Injury - complications</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Benzamides</subject><subject>Bone Marrow - drug effects</subject><subject>Bone Marrow - pathology</subject><subject>Disseminated Intravascular Coagulation - complications</subject><subject>Fatal Outcome</subject><subject>Female</subject><subject>Fusion Proteins, bcr-abl - antagonists &amp; inhibitors</subject><subject>Humans</subject><subject>Imatinib Mesylate</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Middle Aged</subject><subject>Necrosis</subject><subject>Neoplasm Proteins - antagonists &amp; inhibitors</subject><subject>Piperazines - adverse effects</subject><subject>Piperazines - therapeutic use</subject><subject>Pneumonia - complications</subject><subject>Protein Kinase Inhibitors - adverse effects</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Pyrimidines - adverse effects</subject><subject>Pyrimidines - therapeutic use</subject><issn>1592-8721</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j81KxDAUhYMgzjj6CnJfoJCmadMsZfAPZnAz-yFJb2y0TUqSsfTtLairczbn4ztXZFvWkhWtYOWG3Kb0SSmjUoobsinrSgje8i3xR5WS-0bQwSOMKsYwg0cTQ3IJnAcFk8oOfYbZ5R5MH4N3BsYFh2CWvNYBL184OgU2DEOYnf8AN64b7zSMmJZBZYTcY1TTckeurRoS3v_ljpyen0771-Lw_vK2fzwUU8l4LjTykluNVlBrVlljus6wWlEmdV02RiIVQnPdVI2VhpqOto3iUnaSCWGrakcefrHTRY_Ynae4GsXl_P-7-gFTUVaw</recordid><startdate>200409</startdate><enddate>200409</enddate><creator>Tamura, Takahiro</creator><creator>Tasaka, Taizo</creator><creator>Fujimoto, Miharu</creator><creator>Matsuhashi, Yoshiko</creator><creator>Fukumot, Tetsuya</creator><creator>Mano, Shohei</creator><creator>Kuwajima, Minoru</creator><creator>Nagai, Masami</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200409</creationdate><title>Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy</title><author>Tamura, Takahiro ; Tasaka, Taizo ; Fujimoto, Miharu ; Matsuhashi, Yoshiko ; Fukumot, Tetsuya ; Mano, Shohei ; Kuwajima, Minoru ; Nagai, Masami</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p124t-be414fbef70fc153ccddc25a029b516c9e077b4b636f9c0cd086a499d9277f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Acute Kidney Injury - complications</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Benzamides</topic><topic>Bone Marrow - drug effects</topic><topic>Bone Marrow - pathology</topic><topic>Disseminated Intravascular Coagulation - complications</topic><topic>Fatal Outcome</topic><topic>Female</topic><topic>Fusion Proteins, bcr-abl - antagonists &amp; inhibitors</topic><topic>Humans</topic><topic>Imatinib Mesylate</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Middle Aged</topic><topic>Necrosis</topic><topic>Neoplasm Proteins - antagonists &amp; inhibitors</topic><topic>Piperazines - adverse effects</topic><topic>Piperazines - therapeutic use</topic><topic>Pneumonia - complications</topic><topic>Protein Kinase Inhibitors - adverse effects</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Pyrimidines - adverse effects</topic><topic>Pyrimidines - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tamura, Takahiro</creatorcontrib><creatorcontrib>Tasaka, Taizo</creatorcontrib><creatorcontrib>Fujimoto, Miharu</creatorcontrib><creatorcontrib>Matsuhashi, Yoshiko</creatorcontrib><creatorcontrib>Fukumot, Tetsuya</creatorcontrib><creatorcontrib>Mano, Shohei</creatorcontrib><creatorcontrib>Kuwajima, Minoru</creatorcontrib><creatorcontrib>Nagai, Masami</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Haematologica (Roma)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tamura, Takahiro</au><au>Tasaka, Taizo</au><au>Fujimoto, Miharu</au><au>Matsuhashi, Yoshiko</au><au>Fukumot, Tetsuya</au><au>Mano, Shohei</au><au>Kuwajima, Minoru</au><au>Nagai, Masami</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy</atitle><jtitle>Haematologica (Roma)</jtitle><addtitle>Haematologica</addtitle><date>2004-09</date><risdate>2004</risdate><volume>89</volume><issue>9</issue><spage>ECR32</spage><pages>ECR32-</pages><eissn>1592-8721</eissn><cop>Italy</cop><pmid>15377484</pmid></addata></record>
fulltext fulltext
identifier EISSN: 1592-8721
ispartof Haematologica (Roma), 2004-09, Vol.89 (9), p.ECR32
issn 1592-8721
language eng
recordid cdi_pubmed_primary_15377484
source MEDLINE; DOAJ Directory of Open Access Journals
subjects Acute Kidney Injury - complications
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Benzamides
Bone Marrow - drug effects
Bone Marrow - pathology
Disseminated Intravascular Coagulation - complications
Fatal Outcome
Female
Fusion Proteins, bcr-abl - antagonists & inhibitors
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Middle Aged
Necrosis
Neoplasm Proteins - antagonists & inhibitors
Piperazines - adverse effects
Piperazines - therapeutic use
Pneumonia - complications
Protein Kinase Inhibitors - adverse effects
Protein Kinase Inhibitors - therapeutic use
Pyrimidines - adverse effects
Pyrimidines - therapeutic use
title Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T00%3A35%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Massive%20bone%20marrow%20necrosis%20in%20a%20patient%20with%20chronic%20myelocytic%20leukemia%20following%20imatinib%20mesylate%20therapy&rft.jtitle=Haematologica%20(Roma)&rft.au=Tamura,%20Takahiro&rft.date=2004-09&rft.volume=89&rft.issue=9&rft.spage=ECR32&rft.pages=ECR32-&rft.eissn=1592-8721&rft_id=info:doi/&rft_dat=%3Cpubmed%3E15377484%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15377484&rfr_iscdi=true